Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers
- 19 December 2013
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 29 (1) , 173-178
Abstract
There are few data of fibrosis development in chronic hepatitis B (CHB) patients classified as inactive carriers. The aim of this study is to determinate the prevalence of significant fibrosis and probable cirrhosis measured by FibroScan in real inactive CHB carriers and investigate the relationship with virological, epidemiological, and metabolic factors. Cross-sectional cohort study including CHB inactive carriers. Liver stiffness measurement was performed with transient elastography (FibroScan). Significant fibrosis (≥ F2) was defined as stiffness > 7.5 kPa, and probable cirrhosis as > 11.8 kPa. Factors associated with significant fibrosis were explored with univariate and multivariate adjusted logistic regression analyses. Ninety-six CHB inactive carriers were analyzed. Of them, 24 (25%) had significant fibrosis and 7 (7%) probable cirrhosis; mean stiffness was 6.2 ± 2.3 kPa. Of them, 24% had metabolic syndrome, with higher FibroScan value than those without (8.4 kPa vs 5.5 kPa, P < 0.001). Factors associated with significant fibrosis were (odds ratio, 95% confidence interval, P value): central obesity (7.1, 1.8-27.9, 0.005), elevated fasting glucose (4.3, 1.3-27.9, 0.036), reduced high-density lipoprotein cholesterol (5.2, 1.2-23.6, 0.032) and elevated triglycerides (6.2, 1.4-28.3, 0.019). Factors as age, sex, transaminases, hepatitis B virus DNA or genotype were not related with liver fibrosis. The presence of metabolic syndrome has a 69% of positive predictive value and 89% of negative predictive value for significant fibrosis. Different components of metabolic syndrome are associated with fibrosis development in CHB inactive carriers. In the absence of metabolic syndrome, significant fibrosis is uncommon in this population.Keywords
Funding Information
- Fondo de Investigación Sanitaria (CP08/00214, PI10/02166)
- Fundación Profesor Novoa Santos, A Coruña
This publication has 36 references indexed in Scilit:
- Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groupsJournal of Gastroenterology and Hepatology, 2013
- Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic reviewJournal of Hepatology, 2012
- Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis BCurrent Hepatitis Reports, 2011
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human DiseasesCancer Cell, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Insulin Resistance in Chronic Hepatitis B Virus InfectionAmerican Journal of Gastroenterology, 2008
- Virologic and Histologic Features of Chronic Hepatitis B Virus-Infected Asymptomatic Patients With Persistently Normal ALTGastroenterology, 2008
- Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminasesWorld Journal of Gastroenterology, 2008
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006